Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33,940,151
-
Total 13F shares
-
37,129,044
-
Share change
-
+320,543
-
Total reported value
-
$4,166,232,859
-
Put/Call ratio
-
91%
-
Price per share
-
$112.20
-
Number of holders
-
386
-
Value change
-
-$8,088,244
-
Number of buys
-
221
-
Number of sells
-
170
Institutional Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q3 2025
As of 30 Sep 2025,
TransMedics Group, Inc. - Common Stock (TMDX) was held by
386 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,129,044 shares.
The largest 10 holders included
BlackRock, Inc., FMR LLC, VANGUARD GROUP INC, STATE STREET CORP, UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC, MACQUARIE GROUP LTD, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, Driehaus Capital Management LLC, and GOLDMAN SACHS GROUP INC.
This page lists
386
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.